Economic burden of chronic viral hepatitis C
Background. The spread of chronic viral hepatitis C (CVHC) among the population entails significant costs for society, both direct, associated with the treatment of such patients, and indirect, associated with the shortfall in fiscal payments to the budget, due to the disability of this category of...
Saved in:
| Main Authors: | R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-01-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/629 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the global burden of acute viral hepatitis in 2021: addressing health inequalities
by: Lei Zhang, et al.
Published: (2025-05-01) -
Hepatitis C in Lebanon: burden of the disease and value of comprehensive screening and treatment
by: Antoine Abou Rached, et al.
Published: (2018-02-01) -
Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
by: Gyeongseon Shin, et al.
Published: (2025-01-01) -
Geospatial patterns and socioeconomic determinants of the global acute viral hepatitis burden
by: Ke-Jie He, et al.
Published: (2025-06-01) -
Total burden of hepatitis B and C attributed to injecting drug use in 204 countries and territories from 1990 to 2021: Analyses based on the Global Burden of Disease Study 2021
by: Liang Huang, et al.
Published: (2025-01-01)